

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Effect of riboflavin supplementation on blood... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-1034/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-1034" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Effect of riboflavin supplementation on blood pressure and possible effect modification by the MTHFR C677T polymorphism: a randomised trial in rural Gambia" />
    
            <meta name="og:title" content="F1000Research Article: Effect of riboflavin supplementation on blood pressure and possible effect modification by the &lt;i&gt;MTHFR&lt;/i&gt; C677T polymorphism: a randomised trial in rural Gambia.">
            <meta name="og:description" content="Read the latest article version by Modou Jobe, Mary Ward, Bakary Sonko, Abdul Khalie Muhammad, Ebrima Danso, Helene McNulty, Andrew M Prentice, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="27715">
            <meta name="article-id" content="25113">
            <meta name="dc.title" content="Effect of riboflavin supplementation on blood pressure and possible effect modification by the &lt;i&gt;MTHFR&lt;/i&gt; C677T polymorphism: a randomised trial in rural Gambia">
            <meta name="dc.description" content=" Introduction: Emerging evidence links a functional polymorphism in the methylenetetrahydrofolate reductase ( MTHFR ) gene (rs1801133) with hypertension in adults. This variant reduces the affinity of MTHFR for its cofactor flavin-adenine dinucleotide (FAD) which is derived from riboflavin. Previous work has demonstrated a blood pressure (BP)-lowering effect of riboflavin in Irish adults with the MTHFR 677TT variant. We hypothesize that the almost-universal severe riboflavin deficiency seen in rural Gambia mimics the BP phenotypic effect of the TT variant and exacerbate the effect of the CT variant. We will test this in a randomised, placebo-controlled trial, whether intervention with riboflavin can decrease BP in adults in rural Gambia. 
 Methods: This is a phase 2 recall-by-genotype randomised single-blind placebo-controlled riboflavin supplementation trial. We will use the Keneba biobank to recruit approximately 102 individuals aged between 18-70, previously genotyped for the MTHFR C677T polymorphism and identified as carrying the T allele; these individuals will be age- and sex-matched to a similar number of homozygotes for the C allele. The participants will be randomised to a 16-week supplementation trial of 5&amp;nbsp;mg/day riboflavin or placebo, supplied every 14 days. The primary outcome, BP, will be measured at baseline and at weeks 8 and 16. Blood samples, collected at baseline and week 16, will be analysed for riboflavin, homocysteine, red cell folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6). 
 Discussion: The study will evaluate the role of riboflavin supplementation in BP control within a population with high levels of riboflavin deficiency and will test a possible gene-nutrient interaction with the MTHFR C677T polymorphism. If improvements in BP are observed in this study, and proven in subsequent large-scale interventions, riboflavin could offer a cost-effective, safe and accessible option for the &amp;nbsp;prevention and control of hypertension in this population. 
 Trial registration: ClinicalTrials.gov Identifier NCT03151096 . Registered on 12 May 2017.">
            <meta name="dc.subject" content="hypertension, blood pressure, MTHFR, riboflavin, clinical trial">
            <meta name="dc.creator" content="Jobe, Modou">
            <meta name="dc.creator" content="Ward, Mary">
            <meta name="dc.creator" content="Sonko, Bakary">
            <meta name="dc.creator" content="Muhammad, Abdul Khalie">
            <meta name="dc.creator" content="Danso, Ebrima">
            <meta name="dc.creator" content="McNulty, Helene">
            <meta name="dc.creator" content="Prentice, Andrew M">
            <meta name="dc.date" content="2020/08/24">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.25113.1">
            <meta name="dc.source" content="F1000Research 2020 9:1034">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="hypertension">
            <meta name="prism.keyword" content="blood pressure">
            <meta name="prism.keyword" content="MTHFR">
            <meta name="prism.keyword" content="riboflavin">
            <meta name="prism.keyword" content="clinical trial">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/08/24">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="1034">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.25113.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-1034">
            <meta name="citation_title" content="Effect of riboflavin supplementation on blood pressure and possible effect modification by the &lt;i&gt;MTHFR&lt;/i&gt; C677T polymorphism: a randomised trial in rural Gambia">
            <meta name="citation_abstract" content=" Introduction: Emerging evidence links a functional polymorphism in the methylenetetrahydrofolate reductase ( MTHFR ) gene (rs1801133) with hypertension in adults. This variant reduces the affinity of MTHFR for its cofactor flavin-adenine dinucleotide (FAD) which is derived from riboflavin. Previous work has demonstrated a blood pressure (BP)-lowering effect of riboflavin in Irish adults with the MTHFR 677TT variant. We hypothesize that the almost-universal severe riboflavin deficiency seen in rural Gambia mimics the BP phenotypic effect of the TT variant and exacerbate the effect of the CT variant. We will test this in a randomised, placebo-controlled trial, whether intervention with riboflavin can decrease BP in adults in rural Gambia. 
 Methods: This is a phase 2 recall-by-genotype randomised single-blind placebo-controlled riboflavin supplementation trial. We will use the Keneba biobank to recruit approximately 102 individuals aged between 18-70, previously genotyped for the MTHFR C677T polymorphism and identified as carrying the T allele; these individuals will be age- and sex-matched to a similar number of homozygotes for the C allele. The participants will be randomised to a 16-week supplementation trial of 5&amp;nbsp;mg/day riboflavin or placebo, supplied every 14 days. The primary outcome, BP, will be measured at baseline and at weeks 8 and 16. Blood samples, collected at baseline and week 16, will be analysed for riboflavin, homocysteine, red cell folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6). 
 Discussion: The study will evaluate the role of riboflavin supplementation in BP control within a population with high levels of riboflavin deficiency and will test a possible gene-nutrient interaction with the MTHFR C677T polymorphism. If improvements in BP are observed in this study, and proven in subsequent large-scale interventions, riboflavin could offer a cost-effective, safe and accessible option for the &amp;nbsp;prevention and control of hypertension in this population. 
 Trial registration: ClinicalTrials.gov Identifier NCT03151096 . Registered on 12 May 2017.">
            <meta name="citation_description" content=" Introduction: Emerging evidence links a functional polymorphism in the methylenetetrahydrofolate reductase ( MTHFR ) gene (rs1801133) with hypertension in adults. This variant reduces the affinity of MTHFR for its cofactor flavin-adenine dinucleotide (FAD) which is derived from riboflavin. Previous work has demonstrated a blood pressure (BP)-lowering effect of riboflavin in Irish adults with the MTHFR 677TT variant. We hypothesize that the almost-universal severe riboflavin deficiency seen in rural Gambia mimics the BP phenotypic effect of the TT variant and exacerbate the effect of the CT variant. We will test this in a randomised, placebo-controlled trial, whether intervention with riboflavin can decrease BP in adults in rural Gambia. 
 Methods: This is a phase 2 recall-by-genotype randomised single-blind placebo-controlled riboflavin supplementation trial. We will use the Keneba biobank to recruit approximately 102 individuals aged between 18-70, previously genotyped for the MTHFR C677T polymorphism and identified as carrying the T allele; these individuals will be age- and sex-matched to a similar number of homozygotes for the C allele. The participants will be randomised to a 16-week supplementation trial of 5&amp;nbsp;mg/day riboflavin or placebo, supplied every 14 days. The primary outcome, BP, will be measured at baseline and at weeks 8 and 16. Blood samples, collected at baseline and week 16, will be analysed for riboflavin, homocysteine, red cell folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6). 
 Discussion: The study will evaluate the role of riboflavin supplementation in BP control within a population with high levels of riboflavin deficiency and will test a possible gene-nutrient interaction with the MTHFR C677T polymorphism. If improvements in BP are observed in this study, and proven in subsequent large-scale interventions, riboflavin could offer a cost-effective, safe and accessible option for the &amp;nbsp;prevention and control of hypertension in this population. 
 Trial registration: ClinicalTrials.gov Identifier NCT03151096 . Registered on 12 May 2017.">
            <meta name="citation_keywords" content="hypertension, blood pressure, MTHFR, riboflavin, clinical trial">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Modou Jobe">
            <meta name="citation_author_institution" content="Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, Banjul, PO Box 273, The Gambia">
            <meta name="citation_author" content="Mary Ward">
            <meta name="citation_author_institution" content="Northern Ireland Centre for Food and Health, University of Ulster, Ulster, UK">
            <meta name="citation_author" content="Bakary Sonko">
            <meta name="citation_author_institution" content="Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, Banjul, PO Box 273, The Gambia">
            <meta name="citation_author" content="Abdul Khalie Muhammad">
            <meta name="citation_author_institution" content="Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, Banjul, PO Box 273, The Gambia">
            <meta name="citation_author" content="Ebrima Danso">
            <meta name="citation_author_institution" content="Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, Banjul, PO Box 273, The Gambia">
            <meta name="citation_author" content="Helene McNulty">
            <meta name="citation_author_institution" content="Northern Ireland Centre for Food and Health, University of Ulster, Ulster, UK">
            <meta name="citation_author" content="Andrew M Prentice">
            <meta name="citation_author_institution" content="Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, Banjul, PO Box 273, The Gambia">
            <meta name="citation_publication_date" content="2020/08/24">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="1034">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.25113.1">
            <meta name="citation_firstpage" content="1034">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-1034/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-1034.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=27715 /> <input type=hidden id=articleId name=articleId value=25113 /> <input type=hidden id=xmlUrl value="/articles/9-1034/v1/xml"/> <input type=hidden id=xmlFileName value="-9-1034-v1.xml"> <input type=hidden id=article_uuid value=9c183863-5a1c-4c1a-97e0-f570b9f98537 /> <input type=hidden id=referer value=""/> <input type="hidden" id="meta-article-title" value="Effect of riboflavin supplementation on blood pressure and possible effect modification by the <i>MTHFR</i> C677T polymorphism: a randomised trial in rural Gambia" /> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.25113.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.25113.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-1034"
  },
  "headline": "Effect of riboflavin supplementation on blood pressure and possible effect modification by the MTHFR C677T...",
  "datePublished": "2020-08-24T17:33:45",
  "dateModified": "2020-08-24T17:33:45",
  "author": [
    {
      "@type": "Person",
      "name": "Modou Jobe"
    },    {
      "@type": "Person",
      "name": "Mary Ward"
    },    {
      "@type": "Person",
      "name": "Bakary Sonko"
    },    {
      "@type": "Person",
      "name": "Abdul Khalie Muhammad"
    },    {
      "@type": "Person",
      "name": "Ebrima Danso"
    },    {
      "@type": "Person",
      "name": "Helene McNulty"
    },    {
      "@type": "Person",
      "name": "Andrew M Prentice"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Introduction: Emerging evidence links a functional polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene (rs1801133) with hypertension in adults. This variant reduces the affinity of MTHFR for its cofactor flavin-adenine dinucleotide (FAD) which is derived from riboflavin. Previous work has demonstrated a blood pressure (BP)-lowering effect of riboflavin in Irish adults with the MTHFR 677TT variant. We hypothesize that the almost-universal severe riboflavin deficiency seen in rural Gambia mimics the BP phenotypic effect of the TT variant and exacerbate the effect of the CT variant. We will test this in a randomised, placebo-controlled trial, whether intervention with riboflavin can decrease BP in adults in rural Gambia.
Methods: This is a phase 2 recall-by-genotype randomised single-blind placebo-controlled riboflavin supplementation trial. We will use the Keneba biobank to recruit approximately 102 individuals aged between 18-70, previously genotyped for the MTHFR C677T polymorphism and identified as carrying the T allele; these individuals will be age- and sex-matched to a similar number of homozygotes for the C allele. The participants will be randomised to a 16-week supplementation trial of 5 mg/day riboflavin or placebo, supplied every 14 days. The primary outcome, BP, will be measured at baseline and at weeks 8 and 16. Blood samples, collected at baseline and week 16, will be analysed for riboflavin, homocysteine, red cell folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6).
Discussion: The study will evaluate the role of riboflavin supplementation in BP control within a population with high levels of riboflavin deficiency and will test a possible gene-nutrient interaction with the MTHFR C677T polymorphism. If improvements in BP are observed in this study, and proven in subsequent large-scale interventions, riboflavin could offer a cost-effective, safe and accessible option for the  prevention and control of hypertension in this population.
Trial registration: ClinicalTrials.gov Identifier NCT03151096. Registered on 12 May 2017."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-1034/v1",
            "name": "Effect of riboflavin supplementation on blood pressure and possible..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Effect of riboflavin supplementation on blood pressure and possible... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=27715 data-id=25113 data-downloads="" data-views="" data-scholar="10.12688/f1000research.25113.1" data-recommended="" data-doi="10.12688/f1000research.25113.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-1034/v1/pdf?article_uuid=9c183863-5a1c-4c1a-97e0-f570b9f98537" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-25113-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-25113-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-25113-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Jobe M, Ward M, Sonko B <em>et al.</em> Effect of riboflavin supplementation on blood pressure and possible effect modification by the <i>MTHFR</i> C677T polymorphism: a randomised trial in rural Gambia [version 1; peer review: awaiting peer review]</span>. <i>F1000Research</i> 2020, <b>9</b>:1034 (<a class=new-orange href="https://doi.org/10.12688/f1000research.25113.1" target=_blank>https://doi.org/10.12688/f1000research.25113.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-25113-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=25113 id=track-article-signin-25113 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/25113?target=/articles/9-1034/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27715 /> <input name=articleId type=hidden value=25113 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Study Protocol </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Effect of riboflavin supplementation on blood pressure and possible effect modification by the <i>MTHFR</i> C677T polymorphism: a randomised trial in rural Gambia</h1><span class=other-info> [version 1; peer review: awaiting peer review]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:modoujobe@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Modou Jobe</span></a><a href="https://orcid.org/0000-0001-5309-5611" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5309-5611</div><sup>1</sup>,&nbsp;</span><span class="">Mary Ward<sup>2</sup>,&nbsp;</span><span class="">Bakary Sonko<a href="https://orcid.org/0000-0003-3822-2680" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3822-2680</div><sup>1</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Abdul Khalie Muhammad<sup>1</sup>,&nbsp;</span><span class="">Ebrima Danso<sup>1</sup>,&nbsp;</span><span class="">Helene McNulty<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:Andrew.Prentice@lshtm.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Andrew M Prentice</span></a><sup>1</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:modoujobe@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Modou Jobe</span></a><a href="http://orcid.org/0000-0001-5309-5611" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5309-5611</div><sup>1</sup>,&nbsp;</span><span class="">Mary Ward<sup>2</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Bakary Sonko<a href="http://orcid.org/0000-0003-3822-2680" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3822-2680</div><sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Abdul Khalie Muhammad<sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Ebrima Danso<sup>1</sup>,&nbsp;</span><span class="">Helene McNulty<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:Andrew.Prentice@lshtm.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Andrew M Prentice</span></a><sup>1</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 24 Aug 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.25113.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, Banjul, PO Box 273, The Gambia<br/> <sup>2</sup> Northern Ireland Centre for Food and Health, University of Ulster, Ulster, UK<br/> <p> <div class=margin-bottom> Modou Jobe <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Mary Ward <br/> <span>Roles: </span> Conceptualization, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Bakary Sonko <br/> <span>Roles: </span> Data Curation, Investigation, Validation, Writing – Review & Editing </div> <div class=margin-bottom> Abdul Khalie Muhammad <br/> <span>Roles: </span> Formal Analysis, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Ebrima Danso <br/> <span>Roles: </span> Investigation, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Helene McNulty <br/> <span>Roles: </span> Conceptualization, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Andrew M Prentice <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Investigation, Methodology, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <em>AWAITING PEER REVIEW</em> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> <b>Introduction:</b> Emerging evidence links a functional polymorphism in the methylenetetrahydrofolate reductase (<i>MTHFR</i>) gene (rs1801133) with hypertension in adults. This variant reduces the affinity of MTHFR for its cofactor flavin-adenine dinucleotide (FAD) which is derived from riboflavin. Previous work has demonstrated a blood pressure (BP)-lowering effect of riboflavin in Irish adults with the <i>MTHFR</i> 677TT variant. We hypothesize that the almost-universal severe riboflavin deficiency seen in rural Gambia mimics the BP phenotypic effect of the TT variant and exacerbate the effect of the CT variant. We will test this in a randomised, placebo-controlled trial, whether intervention with riboflavin can decrease BP in adults in rural Gambia.<br/> <b>Methods:</b> This is a phase 2 recall-by-genotype randomised single-blind placebo-controlled riboflavin supplementation trial. We will use the Keneba biobank to recruit approximately 102 individuals aged between 18-70, previously genotyped for the <i>MTHFR</i> C677T polymorphism and identified as carrying the T allele; these individuals will be age- and sex-matched to a similar number of homozygotes for the C allele. The participants will be randomised to a 16-week supplementation trial of 5&nbsp;mg/day riboflavin or placebo, supplied every 14 days. The primary outcome, BP, will be measured at baseline and at weeks 8 and 16. Blood samples, collected at baseline and week 16, will be analysed for riboflavin, homocysteine, red cell folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6).<br/> <b>Discussion:</b> The study will evaluate the role of riboflavin supplementation in BP control within a population with high levels of riboflavin deficiency and will test a possible gene-nutrient interaction with the <i>MTHFR</i> C677T polymorphism. If improvements in BP are observed in this study, and proven in subsequent large-scale interventions, riboflavin could offer a cost-effective, safe and accessible option for the &nbsp;prevention and control of hypertension in this population.<br/> <b>Trial registration:</b> ClinicalTrials.gov Identifier <a href="https://clinicaltrials.gov/ct2/show/NCT03151096">NCT03151096</a>. Registered on 12 May 2017. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> hypertension, blood pressure, MTHFR, riboflavin, clinical trial </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Modou Jobe (<a href="mailto:modoujobe@gmail.com">modoujobe@gmail.com</a>) <br> Andrew M Prentice (<a href="mailto:Andrew.Prentice@lshtm.ac.uk">Andrew.Prentice@lshtm.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Modou Jobe, Andrew M Prentice </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This study is funded by the African Partnership for Chronic Disease Research through an APCDR seed award. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Jobe M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Jobe M, Ward M, Sonko B <em>et al.</em> Effect of riboflavin supplementation on blood pressure and possible effect modification by the <i>MTHFR</i> C677T polymorphism: a randomised trial in rural Gambia [version 1; peer review: awaiting peer review]</span>. <i>F1000Research</i> 2020, <b>9</b>:1034 (<a href="https://doi.org/10.12688/f1000research.25113.1" target=_blank>https://doi.org/10.12688/f1000research.25113.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 24 Aug 2020, <b>9</b>:1034 (<a href="https://doi.org/10.12688/f1000research.25113.1" target=_blank>https://doi.org/10.12688/f1000research.25113.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 24 Aug 2020, <b>9</b>:1034 (<a href="https://doi.org/10.12688/f1000research.25113.1" target=_blank>https://doi.org/10.12688/f1000research.25113.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e256>Abbreviations</h2><p class="" id=d41043e259>AE: adverse events; BMI: body mass index; BP: blood pressure; CRF: case report forms; CTSO: clinical trial support office; DAG: data access group; DM: data manager; EGRAC: erythrocyte gluthathione reductase activation coefficient; US FNB: United States Food and Nutrition Board; FAD: flavin-adenine dinucleotide; GCP: Good Clinical Practice; HIGH: Hepcidin and Iron in Global Health; MRCG at LSHTM: Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine; MTHF: methylene tetrahydrofolate; MTHFR: methylene tetrahydrofolate reductase; QC: quality check; PI: principal investigator; REDCap: Research Electronic Data Capture; RNI: Recommended Nutrient Intake; SAE: severe adverse events; SEM: structural equation modelling; SSA: sub-Saharan Africa.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e265>Introduction</h2><p class="" id=d41043e268>Hypertension is a global public health problem affecting 1 billion people worldwide and up to 46% of adults in sub-Saharan Africa (SSA)<sup><a href="#ref-1">1</a></sup>. Despite a generally very low body mass index (BMI) in the rural Kiang West district of The Gambia, the prevalence of high blood pressure (BP) (&gt;140/90) has recently been estimated as 18.3% in adults over 18 years<sup><a href="#ref-2">2</a></sup>. Hypertension arises from a combination of multiple lifestyle and genetic factors (many of which probably remain unknown). Its treatment requires an individualized combination of drug therapy and lifestyle changes<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. The treatment of hypertension is generally lifelong and exerts a heavy economic burden on individuals and their families as well as on national economies. The identification of safe cost-effective treatment interventions without adverse side effects would be hugely advantageous, particularly in low-income settings with high prevalence of hypertension such as SSA.</p><p class="" id=d41043e286>Emerging evidence from clinical and genome-wide association studies (GWAS) links a functional polymorphism in the methylenetetrahydrofolate reductase (<i>MTHFR</i>) gene (rs1801133), encoding the folate-metabolising enzyme MTHFR, with blood pressure (BP) and hypertension in adults<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. This enzyme catalyses the conversion of 5,10-methylenetetrahydrofolate (MTHF) to 5-MTHF. Variation at rs1801133 is relatively common and has 3 genotypes; homozygous “normal” wild-type CC, heterozygous CT and homozygous “variant” TT genotypes. Of these genotypes, the homozygous variant TT is strongly associated with a higher BP. The precise mechanism by which <i>MTHFR</i> C677T is associated with BP remains unclear.</p><p class="" id=d41043e302>Vitamin B2 (riboflavin) is converted to flavin-adenine dinucleotide (FAD) which acts as the essential co-factor for the MTHFR enzyme. Molecular studies demonstrate that the decreased activity of the variant enzyme is caused by reduced affinity for the redox cofactor FAD<sup><a href="#ref-7">7</a></sup>; hence its original name as the ‘heat-labile’ variant. Work at Ulster University has demonstrated, in three separate randomised controlled trials to date, that BP is highly responsive to intervention with riboflavin and that this response is dependent on <i>MTHFR</i> genotype<sup><a href="#ref-8">8</a>–<a href="#ref-10">10</a></sup>. In all of these trials, riboflavin supplementation resulted in significant reductions in both systolic and diastolic BP in adults with the homozygous variant TT genotype, while at baseline (pre-intervention) we observed intermediate BP values in those with the heterozygous CT genotype compared to adults with CC (lower) or TT (higher) genotypes.</p><p class="" id=d41043e319>In the Keneba biobank<sup><a href="#ref-11">11</a></sup>, a total of 2114 individuals between the ages of 18 and 70 were genotyped for rs1801133 of whom 1951 (92.3%) and 163 (7.7%) had the CC and CT genotypes respectively, while none had the TT genotype. We hypothesize that the almost universal severe riboflavin deficiency seen in most Kiang West residents of The Gambia (assessed historically<sup><a href="#ref-12">12</a></sup>) and more recently<sup><a href="#ref-13">13</a></sup> will a) mimic the effect of the TT variant and b) exacerbate the effect of the CT genotype based upon the following argument. <i>In vitro</i> studies show that the TT variant is only 30% saturated with FAD compared to CC and the CT is 84% saturated<sup><a href="#ref-14">14</a></sup>. Riboflavin deficiency is a major problem in Kiang West district with typical values for erythrocyte gluthathione reductase activation coefficient (EGRAC; gold-standard riboflavin biomarker) of &gt;2.0 (compared with indicative values of &lt;1.2, 1.2-1.4 and &gt;1.4, defining normal, suboptimal and deficient status, respectively), indicating that EGR is only 50% saturated by FAD. By analogy, we expect these levels of severe deficiency to lower levels of MTHFR activity by ~50% in CC the genotype and a further 16% in CT variants. This is the basis for the anticipated efficacy of riboflavin supplementation.</p><p class="" id=d41043e342>The adult recommended nutrient intake (RNI) for riboflavin is 1.3 mg/day for men and 1.1 mg/day for women<sup><a href="#ref-15">15</a></sup>. There is no known toxicity (due to a renal threshold whereby unused riboflavin is excreted rapidly in the urine) and the US FNB has noted that there have been no known adverse effects, even at intakes of 400 mg/day for at least 3 months<sup><a href="#ref-16">16</a></sup>. We propose to use just 5 mg/day to replenish body stores and attempt to saturate the CT genotype enzyme as well as aligning the dose with previous trials.</p><p class="" id=d41043e353>The possibility that riboflavin deficiency represents a new, easily-correctible causal factor in hypertension in SSA would require further large-scale interventions if this study yields encouraging results.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e359>Methods/study design</h2><div class=section><a name=d41043e362 class=n-a></a><h3 class=section-title>Study objectives</h3><p class="" id=d41043e367>The primary objective is to compare the effect of 16-weeks of riboflavin supplementation (5 mg/day) versus placebo on systolic and diastolic BP.</p><p class="" id=d41043e370>The secondary objectives are:</p><div class=list><a name=d41043e373 class=n-a></a><ul style="list-style-type: none"><li><p id=d41043e380><span class=label>a) </span> to test for possible effect modification in CC vs CT genotypes for the <i>MTHFR</i> C677T polymorphism on BP response to intervention</p></li><li><p id=d41043e392><span class=label>b) </span> to describe the cross-sectional associations at baseline between BP (continuous variable and proportion with hypertension, &gt;140/90 mmHg) and riboflavin status (assessed by the EGRAC functional biomarker test) and interaction with <i>MTHFR</i> genotype</p></li></ul></div></div><div class=section><a name=d41043e401 class=n-a></a><h3 class=section-title>Study endpoints</h3><p class="" id=d41043e406>The primary outcome is change in BP at 8 and 16 weeks compared to baseline in response to riboflavin supplementation versus placebo. We will also determine the response of the riboflavin biomarker to intervention, determined (before and after riboflavin supplementation) using the EGRAC method, considered to be the gold standard method to assess biomarker status of riboflavin.</p></div><div class=section><a name=d41043e410 class=n-a></a><h3 class=section-title>Trial design</h3><p class="" id=d41043e415>This is a phase 2 recall-by-genotype, randomised single-blind placebo-controlled micronutrient supplementation trial. We will invite all individuals between the ages of 18 and 70 in the Keneba biobank with the CT genotype and a similar number of age- and sex-matched CC homozygotes to participate in the study (<a href="#f1">Figure 1</a>).</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/27715/01dc136e-eb67-4914-b518-c16f45c34a28_figure1.gif"><img alt="01dc136e-eb67-4914-b518-c16f45c34a28_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/27715/01dc136e-eb67-4914-b518-c16f45c34a28_figure1.gif"></a><div class=caption><h3>Figure 1. Schema of Trial design.</h3></div></div></div><div class=section><a name=d41043e436 class=n-a></a><h3 class=section-title>Ethics approval and consent to participate</h3><p class="" id=d41043e441>The study protocol was reviewed by the Scientific Coordinating Committee of the MRCG at LSHTM and has received ethics approval from the Joint Gambia Government/MRC Ethics Committee (SCC1518). Approval was also obtained from the National Medicine Regulatory Authority of The Gambia.</p></div><div class=section><a name=d41043e446 class=n-a></a><h3 class=section-title>Eligibility of participants</h3><p class="" id=d41043e451>Participants must meet all of the inclusion criteria and none of the exclusion criteria to be eligible to participate in the trial.</p><p class="" id=d41043e454><b>Inclusion criteria</b></p><div class=list><a name=d41043e458 class=n-a></a><ul><li><p id=d41043e462>Aged between 18–70 years</p></li><li><p id=d41043e468>Has provided appropriate ethical consent for involvement in studies relating to genetics.</p></li><li><p id=d41043e474>Has available genotype data in the Keneba biobank needed for the current study</p></li><li><p id=d41043e480>Available for the duration of the intervention period</p></li></ul></div><p class="" id=d41043e485><b>Exclusion criteria</b></p><div class=list><a name=d41043e490 class=n-a></a><ul><li><p id=d41043e494>Taking vitamin B/multivitamin supplements</p></li><li><p id=d41043e500>Ongoing pregnancy as confirmed by participant</p></li><li><p id=d41043e506>History of digestive, hepatic, renal, hematological disorders or dementia</p></li><li><p id=d41043e512>Epilepsy or taking anti-epileptic medications</p></li><li><p id=d41043e518>Glucose-6-phosphate dehydrogenase (G6PD) deficiency</p></li></ul></div></div><div class=section><a name=d41043e524 class=n-a></a><h3 class=section-title>Sensitization and consenting</h3><p class="" id=d41043e529>Sensitization of community elders, youth and women groups and respective village residents within the Kiang West district was conducted by the study team prior to recruitment of study participants. During community sensitization, community elders of respective villages were asked to identify literate people to act as impartial witnesses during the consenting process of illiterate potential participants.</p><p class="" id=d41043e532>Individual consent for the study will sought by trained field assistants after explaining the project in full detail, covering all aspects of the study as laid out in the approved study information sheet. Literate participants will be given a copy of the information sheet while illiterate participants will have the full information sheet read to them in the language they understand in the presence of an impartial witness. The fieldworkers answer any questions that arise, and participants are also be given the possibility to obtain further clarifications and explanations by speaking to one of the study investigators if they wish. Participation is entirely voluntary and individuals who are not able to give consent are not enrolled. If participants agree to participate, written informed consent is then obtained. Assessment of informed consent understanding is performed using a specially designed form of 10 questions derived from the participant information sheet (available as <i>Extended data</i><sup><a href="#ref-17">17</a></sup>).</p></div><div class=section><a name=d41043e542 class=n-a></a><h3 class=section-title>Identification of participants and randomisation</h3><p class="" id=d41043e547>The Keneba biobank is used to identify potential participants. After the exclusion criteria are applied and non-consenters are taken into account, we aim to enrol at least 102 participants (see sample size calculations below) with the CT genotype and a similar number of age and sex-matched participants with the CC genotype. A randomisation code, written in Stata, would select each of the participants with the CT genotype and match them to participants with the CC genotype as randomly and equally as possible. This will ensure that all participants with the CT genotype would be age and sex-matched to several possible individuals with the CC genotype. Since each consented CT genotype participant has several possible matches with the CC genotype, consent would be sought until it is obtained from any of the possible matches. Thus if the first participant approached with the CC genotype consents to participate, all other possible matched participants would not be sought after for their consent.</p><p class="" id=d41043e550>Following consent, the participants’ Biobank IDs would be linked to their Study IDs and allocated to receive either riboflavin or placebo by block randomization (of varying block sizes). To ensure balance between the two genotypes, we shall randomly allocate 50% of those with the CT genotype to receive the riboflavin supplement. A programme will perform the randomisation in a 1:1 ratio and produce randomization envelopes to be used. This randomisation is such that for each CT genotype participant that receives the riboflavin supplement the matched participant with the CC genotype is automatically allocated the placebo and vice versa. The randomisation codes and database are accessible only to an independent statistician and data manager.</p></div><div class=section><a name=d41043e554 class=n-a></a><h3 class=section-title>Blinding and un-blinding</h3><p class="" id=d41043e559>Field nurses and field assistants measuring BP and dispensing investigational products to participants, and laboratory staff will be blinded to the genotype of the study participants and to the identity of the treatment arm to which a participant is assigned from the time of randomization to the time of unblinding. Details of matching will also not be revealed to them. The placebos are designed to be indistinguishable from those containing active drugs. The products will be pre-packed with the participant’s name and study ID on a weekly basis by an unblinded study nurse and clinical trial assistant following a study specific protocol and handed over to field assistants who will distribute them to study participants. Double-blinding is not possible because subjects randomized to the riboflavin will have yellow urine, a harmless outcome that will be explained to them at the start of the study and told not to discuss this with any member of the study and other MRCG at LSHTM staff.</p><p class="" id=d41043e562>In this trial, we will ensure that sealed envelopes containing the individual treatment allocation are kept at the Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine (MRCG at LSHTM) field station in Keneba in case of the need for emergency unblinding. The code would be broken in cases of severe adverse events for which the product needs to be known for individual participants.</p><p class="" id=d41043e565>The blinding code will be kept by the independent statistician and will only be broken after the database lock.</p></div><div class=section><a name=d41043e569 class=n-a></a><h3 class=section-title>Data collection and follow-up</h3><p class="" id=d41043e574>At the initial visit, socio-economic data and medical history will be obtained by a field staff using a questionnaire. Anthropometric measurements (height, weight, waist and hip circumference, skin-fold thickness and body composition by bioelectrical impedance analysis) will be taken. Thereafter, BP will be measured with an automated Omron 705IT device (Omron, Kyoto, Japan) in triplicate, each in a seated position and 5 minutes apart, using a standard protocol by the same investigator who will be blinded to genotype and treatment group. The mean of the second and third measurements will be used for analysis. A 10ml blood sample will be collected for laboratory assessment of vitamin B status. During the intervention phase of the trial, we will supplement participants with 5mg/day of riboflavin or a matching placebo for 16 weeks. The pills will be supplied every 10 days with instructions to return any unused pills. Another BP measurement following similar protocol as before will be taken at 8 weeks as well as at 16 weeks post- intervention. Finally, a 10ml blood sample will be collected 16 weeks post-intervention. Blood samples will be analysed for riboflavin (by EGRAC), homocysteine, red cell folate, cobalamin and pyridoxine. Participants will be followed-up after the intervention period for a further 3 weeks to monitor AEs. Details of the study schedule are summarised in <a href="#T1">Table 1</a>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Summary of study schedule.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d41043e591 class=n-a></a><thead><a name=d41043e593 class=n-a></a><tr><a name=d41043e595 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e597 class=n-a></a>Time Point</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e600 class=n-a></a>Visit Number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e603 class=n-a></a>Recruitment</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e606 class=n-a></a>Randomisation</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e609 class=n-a></a>Socioeconomic &amp; Medical History</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e613 class=n-a></a>Anthropometry &amp; Body composition by BIA</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e616 class=n-a></a>Blood Pressure</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e619 class=n-a></a>Blood Sample Collection</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e622 class=n-a></a>Supply of Investigational Product</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41043e625 class=n-a></a>Adverse Events monitoring</th></tr></thead><tbody><a name=d41043e630 class=n-a></a><tr><a name=d41043e632 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e634 class=n-a></a><b>Recruitment</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e638 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e640 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e643 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e646 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e649 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e651 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e653 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e655 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e657 class=n-a></a></td></tr><tr><a name=d41043e660 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e662 class=n-a></a><b>Baseline</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e666 class=n-a></a>0</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e669 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e671 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e673 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e677 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e680 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e683 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e686 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e689 class=n-a></a></td></tr><tr><a name=d41043e692 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e694 class=n-a></a><b>Day 10</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e698 class=n-a></a>1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e701 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e703 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e705 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e708 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e710 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e712 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e714 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e717 class=n-a></a>x</td></tr><tr><a name=d41043e721 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e723 class=n-a></a><b>Day 20</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e727 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e730 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e732 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e734 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e737 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e739 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e741 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e743 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e746 class=n-a></a>x</td></tr><tr><a name=d41043e750 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e752 class=n-a></a><b>Day 30</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e756 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e759 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e761 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e763 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e766 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e768 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e770 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e772 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e775 class=n-a></a>x</td></tr><tr><a name=d41043e780 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e782 class=n-a></a><b>Day 40</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e786 class=n-a></a>4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e789 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e791 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e793 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e796 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e798 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e800 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e802 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e805 class=n-a></a>x</td></tr><tr><a name=d41043e809 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e811 class=n-a></a><b>Day 50</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e815 class=n-a></a>5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e818 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e820 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e822 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e825 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e827 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e829 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e831 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e834 class=n-a></a>x</td></tr><tr><a name=d41043e838 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e840 class=n-a></a><b>Day 60</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e844 class=n-a></a>6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e847 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e849 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e851 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e854 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e856 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e859 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e861 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e864 class=n-a></a>x</td></tr><tr><a name=d41043e868 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e870 class=n-a></a><b>Day 70</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e874 class=n-a></a>7</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e877 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e879 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e881 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e884 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e886 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e888 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e890 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e893 class=n-a></a>x</td></tr><tr><a name=d41043e897 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e899 class=n-a></a><b>Day 80</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e903 class=n-a></a>8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e906 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e908 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e910 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e913 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e915 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e917 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e919 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e922 class=n-a></a>x</td></tr><tr><a name=d41043e926 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e928 class=n-a></a><b>Day 90</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e932 class=n-a></a>9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e935 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e937 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e939 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e942 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e944 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e946 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e948 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e951 class=n-a></a>x</td></tr><tr><a name=d41043e956 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e958 class=n-a></a><b>Day 100</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e962 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e965 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e967 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e969 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e972 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e974 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e976 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e978 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e981 class=n-a></a>x</td></tr><tr><a name=d41043e985 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e987 class=n-a></a><b>Day 110</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e991 class=n-a></a>11</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e994 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e996 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e998 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1001 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1003 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1006 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1009 class=n-a></a>x</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1012 class=n-a></a>x</td></tr><tr><a name=d41043e1016 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1018 class=n-a></a><b>Day 120</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1022 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1025 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1027 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1029 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1032 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1034 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1036 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1038 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1040 class=n-a></a>x</td></tr><tr><a name=d41043e1044 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1046 class=n-a></a><b>Day 130</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1050 class=n-a></a>13</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1053 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1055 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1057 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1060 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1062 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1064 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1066 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1068 class=n-a></a>x</td></tr><tr><a name=d41043e1072 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1074 class=n-a></a><b>Day 140</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1078 class=n-a></a>14</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1081 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1083 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1085 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1088 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1090 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1092 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1094 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d41043e1096 class=n-a></a>x</td></tr></tbody></table></div></div><div class=section><a name=d41043e1104 class=n-a></a><h3 class=section-title>Investigational products</h3><p class="" id=d41043e1109>The investigational products to be used in this study are manufactured by Advanced Molecular Research, Calgary, Canada (<a target=xrefwindow href="https://aor.ca/" id=d41043e1111>https://aor.ca/</a>) following Good Manufacturing Processes and quality control procedures. The products are in the form of capsules, are physically indistinguishable from each other and having the following excipients: microcrystalline cellulose, hypromellose (capsule shell) and chlorophyll (color of the capsule shell) with the supplements (as opposed to placebo) containing 5mg of riboflavin. 10 green capsules are packed in a clear plastic blister and stored as per manufacturer instructions at the MRCG at LSHTM Field Station in Keneba. All used blisters and unused pills will be recovered for accountability purposes as required by local regulations.</p></div><div class=section><a name=d41043e1117 class=n-a></a><h3 class=section-title>Study monitoring</h3><p class="" id=d41043e1122>The trial will be monitored by personnel of MRCG at LSHTM Clinical Trial Support Office as per the sponsor’s regulations. An initiation visit between the monitors, Principal Investigator (PI) and study team was conducted to approve the start of the study. The purpose of this visit is to review ethical approval, the trial master file and required documents (logs, study specific procedures, data collection tools), investigational products, and ensure that study specific training and appropriate facilities are available. An interim visit will be conducted 1 month after the start of the study and then after 6 months. These visits will include the following: review of current status and recruitment rate, verify that the study is conducted in accordance with approved protocols and regulatory requirements and perform source data verification. A close out visit will be conducted at the end of the study to ensure completeness of all essential documents and archiving arrangements, and appropriate distribution of all remaining study products and supplies.</p></div><div class=section><a name=d41043e1126 class=n-a></a><h3 class=section-title>Evaluation of risks and benefits</h3><p class="" id=d41043e1131>The trial will provide 5-mg riboflavin pills or a matching placebo. Riboflavin is safe and because it is water soluble, any excess will be excreted via the urine. No adverse events were observed in studies by our collaborators<sup><a href="#ref-8">8</a>–<a href="#ref-10">10</a></sup> and the US FNB has noted that there have been no known adverse effects of consuming 400 mg/day (80 fold higher than our proposed dose) for at least 3 months<sup><a href="#ref-16">16</a></sup>.</p><p class="" id=d41043e1145>The only potential adverse risk identified in this study relates to blood collection, i.e. pain or discomfort, bruising and infection. The total amount of blood to be collected is 20 ml (10 ml at baseline and at the end of the study) which does not pose any health risk. Our study nurses are sufficiently trained and standard protocols will be used to avoid infection.</p><p class="" id=d41043e1148>Participants who will receive the riboflavin supplements will have their riboflavin stores improved and possibly replenished. Other participants who were randomized to receive placebo will be offered riboflavin supplementation at the end of the study.</p></div><div class=section><a name=d41043e1152 class=n-a></a><h3 class=section-title>Data considerations</h3><p class="" id=d41043e1157><b>Format and scale of data:</b> The database software to be used in this trial is <a target=xrefwindow href="https://www.project-redcap.org/" id=d41043e1161>REDCap</a>. Trial staff trained on GCP and electronic case report forms (eCRF) will be authorized to collect data and other trial specific documentation. Training on REDCap was conducted and they will continue to be updated through in-house training. A web and mobile version of the application installed on mobile tablet devices, smart phones, laptops and PCs will be used at each stage of data collection.</p><p class="" id=d41043e1165>The trial data manager and database developer in consultation designed the eCRFs with input from the PI/sub-investigator and research clinician according to MRCG at LSHTM’s CRF Development standard operating procedure. The eCRFs have built-in quality check (QC) process which aims to minimize the rate of errors/missing fields and enhance data quality. Other quality control measures will include running queries by the DM that will flag discrepancies in the form of missing values, records and outliers. The database developer developed all data entry screens and all reporting functionalities. The final data format can be downloaded to Excel, PDF, and common statistical packages (SPSS, SAS, Stata, R).</p><p class="" id=d41043e1168>The eCRFs will include question fields which are either single or multiple checked, drop-down single selection answers, binary (yes/no) fields, numerical fields and free text. REDCap branching tools will be utilised to guide data collection making sure data is collected on the required activity at each visit. For instance, sample collection and processing data should be allowed to be collected only at visits 00 and 11. Study time points after recruitment and randomisation are categorically numbered 0–14 (<a href="#T1">Table 1</a>). Call lists will be generated to help organize study visits. Strict validation and verification rules will be adhered to when completing the eCRFs. All data collected on mobile tablets collected offline will be synced directly on MRCG at LSHTM dedicated servers accessible only by users within a given Data Access Group (DAG) managed by the software. User access groups for the trial will be granted to trial staff based on individual responsibilities and privileges.</p><p class="" id=d41043e1174><b>System validation:</b> All validation, range logical checks will be applied as required to maintain data integrity. Demographic and clinical data will be imported into the study database but all personally identifiable fields will be marked in REDCap to prevent them from being exported as part of datasets. Data export options from the clinical database include CDISC ODM XML, a vendor neutral, platform independent format for interchange and archive of data collected in clinical trials. This should ensure sharing and long-term validity of data.</p><p class="" id=d41043e1180>All data collection instruments will be continuously reviewed at the various stages of development to ensure that data collected meet the required standards in line with study analysis plan. Data entry screens are designed with rigid validation and logical checks, skip patterns and validations to accurately guide data collection. Study specific procedures (SSPs) and the protocol will guide data collection at the field and in the lab.</p><p class="" id=d41043e1183>Instructions will be embedded on the eCRFs. As part of data supervision, status of the record’s data form completeness, denoted with a colour; red incomplete; yellow unverified; green complete will allow data to be firstly submitted in complete status. The supervisor ensures these records are verified and record status changed to verified in a timely manner.</p><p class="" id=d41043e1186><b>Data validation:</b> Validation checks will be enforced real-time at each stage of data collection which will be programmatically built into the database application to ensure accuracy, consistency and completeness. Primary data will be generated from the field and lab which shall be verified by the study PI or delegate and supervisors.</p><p class="" id=d41043e1191>Other QC checks will be routinely conducted to ensure data collected is of high quality. Participants and visits will be programmed using REDCap calendar to ensure that they are seen on scheduled time points.</p><p class="" id=d41043e1194>Mandatory fields must be completed or flagged for data entry to proceed. Data fields are mainly univariate, allowing only one acceptable value or option. Multivariate checks will be implemented where required. Date fields will be formatted as dd-mm-yyyy and pre-determined ranges applied. Every field will be formatted with the right input masks (e.g. visit number can be masked as regexp: /\d {2}/, to allow two-digits like 01).</p><p class="" id=d41043e1197><b>Data coding:</b> An up-to-date data dictionary will document the study metadata. The data dictionary specifies the database structure normalised to an appropriate level. It specifies database tables, variable names, description types an all properties including all data coding. Categorical and float data will be coded using standard conventions (e.g. 1 = Yes; 0 = No) and range checks on numerical data will ensure plausible data is collected in line with the analysis plan. XML features in REDCap keeps a downloadable up-to-date study metadata.</p><p class="" id=d41043e1203><b>Data capture:</b> For audit purposes, all new and modified records will be logged with the username of the person collecting the data. Data will be captured at each stage using REDCap mobile application installed on tablets that allow data to be collected offline and synced later through a Wi-Fi or mobile data connections. Appropriate rights are allocated and managed by the DM to users. The ability to view any data will be limited and permissions granted by the data manager through DAGs.</p><p class="" id=d41043e1208><b>Query resolution:</b> Due to the real time nature of data collection, queries/errors are expected to be easily detected and resolved immediately. It will be mandatory on all study staff to raise and attend to queries in a timely fashion. In addition, the monitors may raise queries with the team using the same process. A log of all queries handled by the data manager or delegate at any point can show how many queries are raised, resolved, or pending.</p><p class="" id=d41043e1213><b>Data transfer and consolidation:</b> Extracted data requested by the study team will be in the form of CDISC ODM XML or Excel. This will be made available to the recipient through the appropriate medium or as requested by PI. It will be carried out as and when required. Data to be transferred to study PIs would be zipped and password-protected. All data transfers will conform to MRCG at LSHTM data transfer procedures.</p><p class="" id=d41043e1218><b>Safety data reconciliation:</b> Serious adverse events (SAEs) are least expected in this trial but they will be assessed by research clinician and immediately logged and reported to the Clinical Trials Support Office (CTSO) by email alerts. Standard questionnaires will used to report and follow-up SAEs.</p><p class="" id=d41043e1223>Protocol deviations will be reported and kept in the Trial Master File.</p><p class="" id=d41043e1226><b>Database security:</b> All persons dealing with personal data are responsible for ensuring the security and safety of these data. Strict access controls will apply both to the servers and the database. Access to the database is controlled by the Data Manager and any requests for access would be documented.</p><p class="" id=d41043e1232><b>Study closure:</b> Lost to follow-ups would be assessed and after the final trial monitoring visit is completed, the following targets are expected to be met:</p><div class=list><a name=d41043e1237 class=n-a></a><ul><li><p id=d41043e1241>That all data is entered into the study REDCap database and all records marked as complete</p></li><li><p id=d41043e1247>All AEs reported and SAEs followed</p></li><li><p id=d41043e1253>All queries are resolved and data cleaning completed</p></li><li><p id=d41043e1259>Source document verified</p></li><li><p id=d41043e1265>Access rights revoked</p></li></ul></div><p class="" id=d41043e1270>The database would be locked in due course and all accesses denied.</p></div><div class=section><a name=d41043e1274 class=n-a></a><h3 class=section-title>Statistical considerations</h3><p class="" id=d41043e1279><b>Sample size rationale:</b>This pilot trial is constrained by the number of available eligible and consenting adults carrying the <i>MTHFR</i> 677 CT variant. We estimate this will be 102 to be matched to an equal number of CC controls. Using standard deviation estimates from our own and published literature (14 mm for systolic BP and 10 mm for diastolic BP) we will have 95% confidence (at p&lt;0.05) of detecting differences of 3.9 mmHg for systolic BP and 2.8 mmHg for diastolic BP.</p><p class="" id=d41043e1287><b>Statistical analysis plan:</b>A preliminary evaluation of data will be conducted to identify issues that will affect our approach to the primary analysis. This will specifically include the following:</p><div class=list><a name=d41043e1292 class=n-a></a><ul><li><p id=d41043e1296>summarize the amount of missing data for key variables,</p></li><li><p id=d41043e1302>summarize time between baseline and follow-up key measurements</p></li><li><p id=d41043e1308>examine the distributional characteristics of key variables in order to detect potential data entry/reduction errors</p></li></ul></div><p class="" id=d41043e1313>We will also carry out tabulation of descriptive statistics for key variables (including missing observations) and histograms, quantile plots of baseline levels and follow-up measures and changes in those measures will be assessed.</p><p class="" id=d41043e1317>We will also describe the study process to assess whether there is a difference between the trial results compared to the pre-trial plans. “<a href="#T1">Table 1</a>” describing the baseline characteristics of the riboflavin and placebo arm of the trial as well as a CONSORT diagram will also be constructed.</p><p class="" id=d41043e1323>The statistical approached to be used to evaluate the primary and secondary study end points are discussed below:</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e1330>Primary analysis</h2><p class="" id=d41043e1333>We shall use regression to compare differences in BP at week 16 between the two arms of the trial after adjusting for the BP at week 0. The models are summarized below <a name=e1 class=n-a></a><div class="disp-formula panel"><math display=block id=math1 overflow=scroll><mtable columnalign=left><mtr><mtd><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Week</mtext><mspace width="0.3em"></mspace><mn>16</mn></mrow></msub><mo>=</mo><msub><mtext>β</mtext><mn>0</mn></msub><mo>+</mo><msub><mtext>β</mtext><mn>1</mn></msub><msub><mtext>Arm</mtext><mtext>i</mtext></msub><mo>+</mo><msub><mtext>β</mtext><mn>2</mn></msub><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Week</mtext><mspace width="0.3em"></mspace><mn>0</mn></mrow></msub></mtd></mtr><mtr><mtd><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Week</mtext><mspace width="0.3em"></mspace><mn>16</mn></mrow></msub><mo>=</mo><msub><mtext>β</mtext><mn>0</mn></msub><mo>+</mo><msub><mtext>β</mtext><mn>1</mn></msub><msub><mtext>Arm</mtext><mtext>i</mtext></msub><mo>+</mo><msub><mtext>β</mtext><mn>2</mn></msub><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Week</mtext><mspace width="0.3em"></mspace><mn>0</mn></mrow></msub></mtd></mtr></mtable></math></div> for i = (1 for riboflavin and 0 for placebo)</p><p class="" id=d41043e1446>We would perform diagnostics to investigate normality and heretoskedasticity so as to perform a transformation as necessary.</p><p class="" id=d41043e1449>The analyses on BP would be for systolic and diastolic separately. We shall use structural equation modelling (SEM) to predict a latent variable that could reduce the dimension from two to one variable that could reasonably summarize overall change in BP. This would be done by predicting a latent variable for both systolic and diastolic BP at week 0 and week 16 before comparing the two arms using regression as summarized in the model below. <a name=e2 class=n-a></a><div class="disp-formula panel"><math display=block id=math2 overflow=scroll><mrow><msub><mrow><mtext>Overall</mtext><mspace width="0.3em"></mspace><mtext>BP</mtext></mrow><mrow><mtext>week</mtext><mspace width="0.3em"></mspace><mn>16</mn></mrow></msub><msub><mrow><mo>=</mo><mtext>β</mtext></mrow><mn>0</mn></msub><msub><mrow><mo>+</mo><mtext>β</mtext></mrow><mn>1</mn></msub><msub><mrow><mtext>Arm</mtext></mrow><mtext>i</mtext></msub><msub><mrow><mo>+</mo><mtext>β</mtext></mrow><mtext>2</mtext></msub><msub><mrow><mtext>Overall</mtext><mspace width="0.3em"></mspace><mtext>BP</mtext></mrow><mrow><mtext>week</mtext><mspace width="0.3em"></mspace><mn>0</mn></mrow></msub></mrow></math></div></p><p class="" id=d41043e1511>Assessing the relationship between the systolic and diastolic BP with the overall BP would be assessed to see if the relationship is clinically plausible. If it is, then it can be used to test whether, holistically, BP at week 16 is different between the riboflavin arm and the placebo arm, adjusting for overall BP at week 0.</p><p class="" id=d41043e1515><b><i>Missing data</i></b>: Missing data less than 5% (below the 102 participants required for adequate power in the sample size calculation) would be considered acceptable to do a complete case analysis. In the event that the missing data is or above 5% we shall use Multiple Imputation to minimize bias.</p><p class="" id=d41043e1521><b><i>Interpretation</i></b>: We shall reject the null hypothesis that there is no difference between the riboflavin arm and the placebo arm at a 5% significance level. A statistically significant result between the arms where the mean BP (separated or overall) for participants that received riboflavin is lower than the mean of the participants that received placebo would mean that riboflavin successfully lowers BP 16 weeks after administration.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e1530>Secondary analyses</h2><p class="" id=d41043e1533>We shall use regression to ascertain whether there is effect modification of the intervention due to the genotype. The models are summarized below <a name=e3 class=n-a></a><div class="disp-formula panel"><math display=block id=math3 overflow=scroll><mtable columnalign=left><mtr><mtd><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Wk</mtext><mspace width="0.2em"></mspace><mtext>16</mtext></mrow></msub><mo>=</mo><msub><mtext>β</mtext><mn>0</mn></msub><mo>+</mo><msub><mtext>β</mtext><mn>1</mn></msub><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Wk</mtext><mspace width="0.2em"></mspace><mn>0</mn></mrow></msub><mo>+</mo><msub><mtext>β</mtext><mtext>2</mtext></msub><msub><mtext>Arm</mtext><mtext>i</mtext></msub><mo>+</mo><msub><mtext>β</mtext><mtext>3</mtext></msub><msub><mtext>Genotype</mtext><mtext>j</mtext></msub><mo>+</mo><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mrow><mtext>23</mtext></mrow></msub><msub><mtext>Arm</mtext><mtext>i</mtext></msub><msub><mtext>Genotype</mtext><mtext>j</mtext></msub></mtd></mtr><mtr><mtd><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Wk</mtext><mspace width="0.2em"></mspace><mtext>16</mtext></mrow></msub><mo>=</mo><msub><mtext>β</mtext><mn>0</mn></msub><mo>+</mo><msub><mtext>β</mtext><mn>1</mn></msub><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>Wk</mtext><mspace width="0.2em"></mspace><mn>0</mn></mrow></msub><mo>+</mo><msub><mtext>β</mtext><mtext>2</mtext></msub><msub><mtext>Arm</mtext><mtext>i</mtext></msub><mo>+</mo><msub><mtext>β</mtext><mtext>3</mtext></msub><msub><mtext>Genotype</mtext><mtext>j</mtext></msub><mo>+</mo><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mrow><mtext>23</mtext></mrow></msub><msub><mtext>Arm</mtext><mtext>i</mtext></msub><msub><mtext>Genotype</mtext><mtext>j</mtext></msub></mtd></mtr></mtable></math></div> for i = (1 for riboflavin and 0 for placebo)</p><p class="" id=d41043e1708>Similarly diagnostics would be performed to assess none of the assumptions of regression were violated and ensure that proper methods would be used to address any violations.</p><p class="" id=d41043e1711><b><i>Interpretation</i></b>: We shall reject the null hypothesis that there is no effect modification at a 5% significance level.</p><p class="" id=d41043e1717>We shall use regression to ascertain whether there is an association between EGRAC based riboflavin status and systolic and diastolic BP at both week 0 and week 16. This is when we are considering the BPs as continuous. The models are summarized below. <a name=e4 class=n-a></a><div class="disp-formula panel"><math display=block id=math4 overflow=scroll><mtable columnalign=left><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>1</mtext></msub><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext></mrow></msub></mtd></mtr><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>1</mtext></msub><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn></mrow></msub></mtd></mtr><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext></mrow></msub></mtd></mtr><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>1</mtext></msub><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn></mrow></msub></mtd></mtr></mtable></math></div></p><p class="" id=d41043e1908>The models that use a BP cut-off of 140 mmHg for systolic and 90 mmHg for diastolic are similar to the ones above. <a name=e5 class=n-a></a><div class="disp-formula panel"><math display=block id=math5 overflow=scroll><mtable columnalign=left><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>1</mtext></msub><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext><mspace width="0.3em"></mspace><mtext>i</mtext></mrow></msub></mtd></mtr><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>1</mtext></msub><mtext>Systolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn><mspace width="0.3em"></mspace><mtext>i</mtext></mrow></msub></mtd></mtr><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mtext>0</mtext><mspace width="0.3em"></mspace><mtext>j</mtext></mrow></msub></mtd></mtr><mtr><mtd><mtext>EGRAC</mtext><mspace width="0.3em"></mspace><msub><mtext>Riboflavin</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn></mrow></msub><mspace width="0.2em"></mspace><mtext>=</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>0</mtext></msub><mtext>+</mtext><mspace width="0.3em"></mspace><msub><mtext>β</mtext><mtext>1</mtext></msub><mtext>Diastolic</mtext><mspace width="0.3em"></mspace><msub><mtext>BP</mtext><mrow><mtext>wk</mtext><mspace width="0.3em"></mspace><mspace width="0.2em"></mspace><mn>16</mn><mspace width="0.3em"></mspace><mtext>i</mtext></mrow></msub></mtd></mtr></mtable></math></div> for i = (1 for 140 mmHg and above and 0 for less than 140 mmHg) j = (1 for 90 mmHg and above and 0 for less than 90 mmHg)</p><p class="" id=d41043e2111>Diagnostics would be performed to assess and correct violation of any regression assumptions as appropriate.</p><p class="" id=d41043e2114>We shall also assess the effect modification by the <i>MTHFR</i> genotype using both continuous and dichotomized BP measurements. These models would also be diagnosed and violations addressed accordingly.</p><p class="" id=d41043e2120><b><i>Interpretation</i></b>: We shall reject the null hypothesis that there is no effect modification at a 5% significance level.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e2130>Discussion</h2><p class="" id=d41043e2133>High BP is a public health problem, especially in SSA. The causes are not fully understood in the vast majority of cases and commonly result from a combination of lifestyle and genetic factors. The treatment of high BP is often very expensive and sometimes not affordable especially in poor communities. The development of low-cost, effective treatments would therefore be hugely beneficial.</p><p class="" id=d41043e2136>It is possible that the severe riboflavin deficiency observed in the Kiang West district and possibly in other parts of SSA may be contributing to the rising prevalence of high BP, especially among those with a genetic predisposition for developing hypertension owing to <i>MTHFR</i> 677CT genotype. The study will represent the first step in helping us to understand if riboflavin supplementation helps to control blood pressure in this population group. If improvements in BP were achieved in this study and proven in large-scale intervention, it would offer a novel means of controlling hypertension that would be safer, more accessible and more cost-effective than current treatment options.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e2145>Trial status</h2><p class="" id=d41043e2148>A total of 122 participants have been randomised into the study at the time of submission.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e2154>Declarations</h2></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41043e2160>Data availability</h2><div class=section><a name=d41043e2163 class=n-a></a><h3 class=section-title>Underlying data</h3><p class="" id=d41043e2168>No underlying data are associated with this article.</p></div><div class=section><a name=d41043e2172 class=n-a></a><h3 class=section-title>Extended data</h3><p class="" id=d41043e2177>Figshare: RiboBP_SPIRIT Checklist.docx. <a target=xrefwindow href="https://doi.org/10.6084/m9.figshare.12627902.v1" id=d41043e2179>https://doi.org/10.6084/m9.figshare.12627902.v1</a><sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d41043e2186>File ‘Prentice_SCC 1518_ICD_version4.0.docx’ contains the participant information sheet used in this study.</p></div><div class=section><a name=d41043e2190 class=n-a></a><h3 class=section-title>Reporting guidelines</h3><p class="" id=d41043e2195>Figshare: SPIRIT checklist for ‘Effect of riboflavin supplementation on blood pressure and possible effect modification by the <i>MTHFR</i> C677T polymorphism: a randomised trial in rural Gambia. <a target=xrefwindow href="https://doi.org/10.6084/m9.figshare.12627902.v1" id=d41043e2200>https://doi.org/10.6084/m9.figshare.12627902.v1</a><sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d41043e2207>Data are available under the terms of the <a target=xrefwindow href="https://creativecommons.org/licenses/by/4.0/legalcode" id=d41043e2209>Creative Commons Attribution 4.0 International license</a> (CC-BY 4.0).</p></div></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d41043e2218 class=n-a></a><h2 class=main-title id=d41043e2220>Acknowledgements</h2><p class="" id=d41043e2223>We would like to express gratitude to Traj Nibber of Advanced Orthomolecular Research, Calgary, Canada for providing the investigational products to be used in this study. We would like to thank the entire study team: Kabiru Ceesay, Ousubie Jawla, Seedy Singhateh, Lamin Ceesay, Buba Ceesay, Siaka Gaye, Omar Darboe, Omar Jallow, Wandifa Cham, Ansumana Kombo, Alhassan Colley, Sainey Beyai and Buba Sonko and to the entire MRCG at LSHTM staff at Keneba for their hard work and dedication. We are also grateful to the Clinical Trial Support Office at MRCG at LSHTM for monitoring this trial and for their helpful suggestions. Special thanks go to all participants as well as impartial witnesses in making this trial a success.</p></div><div class=back-section><a name=d41043e2227 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading is-hidden"><span class=faculty-opinion-icon></span><span class="prime-red big">Faculty Opinions recommended</span></span><h2 class=main-title id=d41275>References</h2><div class="section ref-list"><a name=d41043e2227 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d41043e2234 class=n-a></a>World Health Organization: A Global Brief on Hypertension. 2013; Geneva: World Health Organization. <a target=xrefwindow id=d41043e2236 href="https://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d41043e2245 class=n-a></a>Jobe M, Agbla SC, Prentice AM, <i> et al.</i>: High blood pressure and associated risk factors as indicator of preclinical hypertension in rural West Africa: A focus on children and adolescents in The Gambia. <i>Medicine (Baltimore).</i> 2017; <b>96</b>(13): e6170. <a target=xrefwindow id=d41043e2256 href="http://www.ncbi.nlm.nih.gov/pubmed/28353557">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2259 href="https://doi.org/10.1097/MD.0000000000006170">Publisher Full Text </a> | <a target=xrefwindow id=d41043e2263 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5380241">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d41043e2272 class=n-a></a>Mancia G, Fagard R, Narkiewicz K, <i> et al.</i>: 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). <i>Eur Heart J.</i> 2013; <b>34</b>(28): 2159–219. <a target=xrefwindow id=d41043e2283 href="http://www.ncbi.nlm.nih.gov/pubmed/23771844">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2286 href="https://doi.org/10.1093/eurheartj/eht151">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d41043e2295 class=n-a></a>Whelton PK, Carey RM, Aronow WS, <i> et al.</i>: 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol.</i> 2017. <a target=xrefwindow id=d41043e2303 href="https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2017/Guidelines_Made_Simple_2017_HBP.pdf">Reference Source</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d41043e2312 class=n-a></a>Yang B, Fan S, Zhi X, <i> et al.</i>: Associations of <i>MTHFR</i> gene polymorphisms with hypertension and hypertension in pregnancy: A meta-analysis from 114 studies with 15411 cases and 21970 controls. <i>PLoS One.</i> 2014; <b>9</b>(2): e87497. <a target=xrefwindow id=d41043e2326 href="http://www.ncbi.nlm.nih.gov/pubmed/24505291">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2330 href="https://doi.org/10.1371/journal.pone.0087497">Publisher Full Text </a> | <a target=xrefwindow id=d41043e2333 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3914818">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d41043e2343 class=n-a></a>McNulty H, Strain JJ, Hughes CF, <i> et al.</i>: Riboflavin, <i>MTHFR</i> genotype and blood pressure: A personalized approach to prevention and treatment of hypertension. <i>Mol Aspects Med.</i> 2017; <b>53</b>: 2–9. <a target=xrefwindow id=d41043e2357 href="http://www.ncbi.nlm.nih.gov/pubmed/27720779">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2361 href="https://doi.org/10.1016/j.mam.2016.10.002">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d41043e2370 class=n-a></a>Yamada K, Chen Z, Rozen R, <i> et al.</i>: Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. <i>Proc Natl Acad Sci U S A.</i> 2001; <b>98</b>(26): 14853–8. <a target=xrefwindow id=d41043e2381 href="http://www.ncbi.nlm.nih.gov/pubmed/11742092">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2384 href="https://doi.org/10.1073/pnas.261469998">Publisher Full Text </a> | <a target=xrefwindow id=d41043e2388 href="http://www.ncbi.nlm.nih.gov/pmc/articles/64948">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d41043e2397 class=n-a></a>Horigan G, McNulty H, Ward M, <i> et al.</i>: Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C--&gt;T polymorphism in <i>MTHFR</i>. <i>J Hypertens.</i> 2010; <b>28</b>(3): 478–86. <a target=xrefwindow id=d41043e2411 href="http://www.ncbi.nlm.nih.gov/pubmed/19952781">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2415 href="https://doi.org/10.1097/HJH.0b013e328334c126">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d41043e2424 class=n-a></a>Wilson CP, McNulty H, Ward M, <i> et al.</i>: Blood pressure in treated hypertensive individuals with the <i>MTHFR</i> 677TT genotype is responsive to intervention with riboflavin: Findings of a targeted randomized trial. <i>Hypertension.</i> 2013; <b>61</b>(6): 1302–8. <a target=xrefwindow id=d41043e2438 href="http://www.ncbi.nlm.nih.gov/pubmed/23608654">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2442 href="https://doi.org/10.1161/HYPERTENSIONAHA.111.01047">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d41043e2451 class=n-a></a>Wilson CP, Ward M, McNulty H, <i> et al.</i>: Riboflavin offers a targeted strategy for managing hypertension in patients with the <i>MTHFR</i> 677TT genotype: A 4-y follow-up. <i>Am J Clin Nutr.</i> 2012; <b>95</b>(3): 766–72. <a target=xrefwindow id=d41043e2465 href="http://www.ncbi.nlm.nih.gov/pubmed/22277556">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2469 href="https://doi.org/10.3945/ajcn.111.026245">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d41043e2478 class=n-a></a>Hennig BJ, Unger SA, Dondeh BL, <i> et al.</i>: Cohort profile: The Kiang West Longitudinal Population Study (KWLPS)-a platform for integrated research and health care provision in rural Gambia. <i>Int J Epidemiol.</i> 2017; <b>46</b>(2): e13. <a target=xrefwindow id=d41043e2489 href="http://www.ncbi.nlm.nih.gov/pubmed/26559544">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2492 href="https://doi.org/10.1093/ije/dyv206">Publisher Full Text </a> | <a target=xrefwindow id=d41043e2496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5837564">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d41043e2506 class=n-a></a>Bates CJ, Powers HJ: Studies on micronutrient intakes and requirements in The Gambia. <i>J Hum Nutr Diet.</i> 1989; <b>2</b>(2): 117–24. <a target=xrefwindow id=d41043e2514 href="https://doi.org/10.1111/j.1365-277X.1989.tb00016.x">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d41043e2523 class=n-a></a>Dominguez-Salas P, Moore SE, Cole D, <i> et al.</i>: DNA methylation potential: Dietary intake and blood concentrations of one-carbon metabolites and cofactors in rural African women. <i>Am J Clin Nutr.</i> 2013; <b>97</b>(6): 1217–27. <a target=xrefwindow id=d41043e2534 href="http://www.ncbi.nlm.nih.gov/pubmed/23576045">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2537 href="https://doi.org/10.3945/ajcn.112.048462">Publisher Full Text </a> | <a target=xrefwindow id=d41043e2541 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3652920">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d41043e2550 class=n-a></a>Frosst P, Blom HJ, Milos R, <i> et al.</i>: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. <i>Nat Genet.</i> 1995; <b>10</b>(1): 111–3. <a target=xrefwindow id=d41043e2561 href="http://www.ncbi.nlm.nih.gov/pubmed/7647779">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2564 href="https://doi.org/10.1038/ng0595-111">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d41043e2573 class=n-a></a>Vitamin and mineral requirements in human nutrition: report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September 1998. <a target=xrefwindow id=d41043e2575 href="https://www.worldcat.org/title/vitamin-and-mineral-requirements-in-human-nutrition-report-of-a-joint-faowho-expert-consultation-bangkok-thailand-21-30-september-1998/oclc/560439678">Reference Source</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d41043e2584 class=n-a></a>Institute of Medicine. Food and Nutrition Board: Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B<sub>6</sub>, Folate, Vitamin B<sub>12</sub>, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998. <a target=xrefwindow id=d41043e2592 href="http://www.ncbi.nlm.nih.gov/pubmed/23193625">PubMed Abstract </a> | <a target=xrefwindow id=d41043e2595 href="https://doi.org/10.17226/6015">Publisher Full Text </a> | <a target=xrefwindow id=d41043e2598 href="http://www.ncbi.nlm.nih.gov/pmc/articles/NBK114310">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d41043e2607 class=n-a></a>Jobe M, Ward M, Sonko B, <i> et al.</i>: RiboBP_SPIRIT Checklist and informed consent document.docx [Internet] <i>figshare.</i> 2020; [cited 2020Jul11]. <a target=xrefwindow id=d41043e2615 href="http://www.doi.org/10.6084/m9.figshare.12627902">http://www.doi.org/10.6084/m9.figshare.12627902</a></span></li></ul></div></div></div> </div> <div class=f1r-article-desk> <section class="o-box o-box--medium u-bg--2 u-mt--2"> <h4 class="u-mt--0 u-mb--2 t-h3 u-weight--md">Looking for the Open Peer Review Reports?</h4> <p class="u-mt--0 u-mb--0 t-h4">They can now be found at the top of the panel on the right, linked from the box entitled Open Peer Review. Choose the reviewer report you wish to read and click the 'read' link. You can also read all the peer review reports by <a target=_blank href="https://f1000research.com/articles/9-1034/v1/pdf?article_uuid=9c183863-5a1c-4c1a-97e0-f570b9f98537">downloading the PDF</a>.</p> </section> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Aug 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-1034/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-1034/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, Banjul, PO Box 273, The Gambia<br/> <sup>2</sup> Northern Ireland Centre for Food and Health, University of Ulster, Ulster, UK<br/> <p> <div class=margin-bottom> Modou Jobe <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Mary Ward <br/> <span>Roles: </span> Conceptualization, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Bakary Sonko <br/> <span>Roles: </span> Data Curation, Investigation, Validation, Writing – Review & Editing </div> <div class=margin-bottom> Abdul Khalie Muhammad <br/> <span>Roles: </span> Formal Analysis, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Ebrima Danso <br/> <span>Roles: </span> Investigation, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Helene McNulty <br/> <span>Roles: </span> Conceptualization, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Andrew M Prentice <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Investigation, Methodology, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-1034/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 24 Aug 2020, 9:1034 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.25113.1">https://doi.org/10.12688/f1000research.25113.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Jobe M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=27715 data-id=25113 data-downloads="" data-views="" data-scholar="10.12688/f1000research.25113.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-1034/v1/pdf?article_uuid=9c183863-5a1c-4c1a-97e0-f570b9f98537" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.25113.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Jobe M, Ward M, Sonko B <em>et al.</em> Effect of riboflavin supplementation on blood pressure and possible effect modification by the <i>MTHFR</i> C677T polymorphism: a randomised trial in rural Gambia [version 1; peer review: awaiting peer review] <i>F1000Research</i> 2020, <b>9</b>:1034 (<a href="https://doi.org/10.12688/f1000research.25113.1" target=_blank>https://doi.org/10.12688/f1000research.25113.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=25113 id=mobile-track-article-signin-25113 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/25113?target=/articles/9-1034/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27715 /> <input name=articleId type=hidden value=25113 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status no-border-and-margin "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <div class=f1r-article-desk-inline><em>AWAITING PEER REVIEW</em></div> <div class="f1r-article-mobile-inline float-right"><em>AWAITING PEER REVIEW</em></div> <span class="circle-icon-small to-right" data-window=about-referee-status title=Help>?</span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Aug 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-1034/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-1034/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <div class="p-article__sidebar-highlight u-mb--2"> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="u-ib u-middle"><em>AWAITING PEER REVIEW</em></div> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-1034/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-1034/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Effect of riboflavin supplementation on blood...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-1034/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-1034/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-1034/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Jobe M et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-1034/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-1034",
            templates : {
                twitter : "Effect of riboflavin supplementation on blood pressure and possible.... Jobe M et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-1034/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Effect of riboflavin supplementation on blood pressure and possible effect modification by the MTHFR C677T polymorphism: a randomised trial in rural Gambia", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Study Protocol", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Effect of riboflavin supplementation on blood pressure and possible effect modification by the MTHFR C677T polymorphism: a randomised trial in rural Gambia", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/25113/27715")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("articles", "article", "27715");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "70161": 0,
                           "70160": 0,
                           "70162": 0,
                           "70148": 0,
                           "70157": 0,
                           "70159": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "cb5914c1-02e3-4367-90ad-cf43f5a3d118";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-1034.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-1034.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-1034.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-1034.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-1034.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>